Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

BioLineRx seeks German approval to begin Phase IIb trial of leukemia drug candidate BL-8040 By PBR Staff Writer
Israeli biopharmaceutical firm BioLineRx has submitted regulatory applications to the German Federal Institute for Drugs and Medical Devices (BfArM) seeking approval to begin a Phase IIb trial of its clinical-stage drug candidate BL-8040 as a new consolidation treatment for acute myeloid leukemia (AML).
Drug Research > Drug Discovery & Development > News
Alizé Pharma begins Phase II trial of AZP-531 to treat Prader-Willi syndrome By PBR Staff Writer
France-based Alizé Pharma has started a Phase II clinical trial of AZP-531, its unacylated ghrelin analog, to treat patients with Prader-Willi syndrome, a rare genetic metabolic syndrome.
Drug Research > Drug Discovery & Development > News CEL-SCI gets clearance to conduct Phase III trial of cancer drug Multikine in 21 countries By PBR Staff Writer
US-based biotechnology firm CEL-SCI has received clearance from the Ministry of Health of the Republic of Belarus to begin patient enrollment in the Phase III trial of its investigational cancer immunotherapy Multikine (Leukocyte Interleukin, Injection) in Belarus to treat head and neck cancer.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Triphase, Sunnybrook to advance development new bi-specific antibody for cancer patients
By PBR Staff Writer
US-based Triphase Accelerator has entered into an academic center collaboration with Canada's Sunnybrook Research Institute to advance development of its new, first-in-class, fully human bi-specific antibody TRPH 011 and evaluate the role of bifunctional targeting of VEGFR-2 and TIE 2 receptors in cancer patients.
Drug Research > Drug Discovery & Development > News
Modalities
Modalities include a dedicated device, a smartphone app and IWRS.
Drug Research > Drug Discovery & Development > Products
Respiratory Devices
Respiratory devices include: MasterScope® CT, FlowScreen® CT, AM3 ®, AM1+ ®, SpiroPro® CT and Clean Peak Flow Meter®.
Drug Research > Drug Discovery & Development > Products
ABPM Collection Devices
ABPM collection devices include the Mortara Ambulo™ 2400.
Drug Research > Drug Discovery & Development > Products
ECG Collection Devices
Products include: ELI-PC 12- Lead ECG, ELI 150, ELI 10, ELI 250, MAC 1200.
Drug Research > Drug Discovery & Development > Products
MedImmune, NIST partner to advance drug discovery and manufacturing
By PBR Staff Writer
AstraZeneca's biologics research and development arm MedImmune will partner with US Department of Commerce’s National Institute of Standards and Technology (NIST) to advance development of biological therapies.
Drug Research > Drug Discovery & Development > News
Takeda, UK’s QMUL partner to develop new therapies for gastrointestinal diseases
By PBR Staff Writer
Japan-based Takeda Pharmaceutical Company (Takeda) has entered into a research collaboration with Queen Mary University of London (QMUL) to define new insights and develop novel therapies for the treatment of gastrointestinal (GI) diseases.
Drug Research > Drug Discovery & Development > News
Alzheimer's Research UK launches £30m dementia drug discovery alliance
By PBR Staff Writer
Alzheimer's Research UK has launched a £30m Drug Discovery Alliance, which will see research centres use their expertise to discover drugs for dementia.
Drug Research > Drug Discovery & Development > News
Best Practices for Streamlining Electronic Implementation of Established COAs; Copyright January 2015
| By ERT
This paper addresses the best practices for building an electronic Clinical Outcome Assessment (eCOA) solution in support of clinical research as it relates to the operational and licensing compliance aspects of administering COAs on electronic platforms.
Drug Research > Drug Discovery & Development > White Papers
View all Drug Discovery & Development news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250